|
SUDS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.412600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.443300E-03 |
| Normal-vs-Stage2 |
3.225600E-02 |
| Normal-vs-Stage3 |
8.41000000000314E-05 |
| Normal-vs-Stage4 |
6.764900E-04 |
| Stage1-vs-Stage2 |
7.403200E-01 |
| Stage1-vs-Stage3 |
1.897770E-01 |
| Stage1-vs-Stage4 |
3.674000E-01 |
| Stage2-vs-Stage3 |
2.112400E-01 |
| Stage2-vs-Stage4 |
3.522600E-01 |
| Stage3-vs-Stage4 |
7.910800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.204300E-04 |
| Normal-vs-AfricanAmerican |
1.724150E-01 |
| Normal-vs-Asian |
5.804800E-03 |
| Caucasian-vs-AfricanAmerican |
2.937200E-01 |
| Caucasian-vs-Asian |
6.446600E-01 |
| AfricanAmerican-vs-Asian |
4.738000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.46050000000709E-05 |
| Normal-vs-Female |
1.699140E-03 |
| Male-vs-Female |
2.011600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.801500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.558120E-03 |
| Normal-vs-Age(61-80Yrs) |
3.821500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.724200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.230000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.556800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.482600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.765400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.432000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.551600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.053830E-01 |
| Classical-VS-Follicular |
7.463400E-01 |
| Classical-VS-Other |
5.885600E-01 |
| Classical-VS-Normal |
2.098200E-03 |
| Tall-VS-Follicular |
2.202800E-01 |
| Tall-VS-Other |
7.632600E-01 |
| Tall-VS-Normal |
6.606400E-04 |
| Follicular-VS-Other |
7.657400E-01 |
| Follicular-VS-Normal |
1.173800E-02 |
| Other-VS-Normal |
1.004950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.407400E-04 |
| Normal-vs-N1 |
3.237200E-04 |
| N0-vs-N1 |
4.867200E-01 |
|
|
